OptimizeRx (OPRX)
(Delayed Data from NSDQ)
$10.12 USD
+1.32 (15.00%)
Updated Apr 26, 2024 03:59 PM ET
After-Market: $10.12 0.00 (0.00%) 7:58 PM ET
2-Buy of 5 2
D Value D Growth C Momentum D VGM
Brokerage Reports
0 items in cart
OptimizeRx Corp. [OPRX]
Reports for Purchase
Showing records 1 - 20 ( 121 total )
Company: OptimizeRx Corp.
Industry: Computer - Software
Company: OptimizeRx Corp.
Industry: Computer - Software
Preliminary Earnings Data Support Bullish Thesis
Provider: Roth Capital Partners, Inc.
Analyst: BALDRY R
Company: OptimizeRx Corp.
Industry: Computer - Software
Company: OptimizeRx Corp.
Industry: Computer - Software
Company: OptimizeRx Corp.
Industry: Computer - Software
Company: OptimizeRx Corp.
Industry: Computer - Software
Acquisition and Cost Controls Set To Increase Revenue and Earnings Scale
Provider: Roth Capital Partners, Inc.
Analyst: BALDRY R
Company: OptimizeRx Corp.
Industry: Computer - Software
Company: OptimizeRx Corp.
Industry: Computer - Software
Slow Growth Rebound Emerging But Behind Expectations; PT Cut to $20.00
Provider: Roth Capital Partners, Inc.
Analyst: BALDRY R
Company: OptimizeRx Corp.
Industry: Computer - Software
Company: OptimizeRx Corp.
Industry: Computer - Software
Midyear Strategic Update" Affirms Growth Rebound Expectation
Provider: Roth Capital Partners, Inc.
Analyst: BALDRY R
Company: OptimizeRx Corp.
Industry: Computer - Software
Company: OptimizeRx Corp.
Industry: Computer - Software
Company: OptimizeRx Corp.
Industry: Computer - Software
Company: OptimizeRx Corp.
Industry: Computer - Software
Pharma Spending Weakness Persists But Glimmers of Hope Emerging
Provider: Roth Capital Partners, Inc.
Analyst: BALDRY R
Company: OptimizeRx Corp.
Industry: Computer - Software
Weak Yr/Yr Results Belie Early Strength Signals From New RWE Offering
Provider: Roth Capital Partners, Inc.
Analyst: BALDRY R
Company: OptimizeRx Corp.
Industry: Computer - Software
Company: OptimizeRx Corp.
Industry: Computer - Software
Company: OptimizeRx Corp.
Industry: Computer - Software
Downside Results Widely Miss; Cutting Price Target to $31.00
Provider: Roth Capital Partners, Inc.
Analyst: BALDRY R
Company: OptimizeRx Corp.
Industry: Computer - Software
Software: Upcoming London Conference Offers Timely Access
Provider: Roth Capital Partners, Inc.
Analyst: BALDRY R
Company: OptimizeRx Corp.
Industry: Computer - Software
High Beta Macro Attack Mistakenly Targets Defensible Fast-Growers
Provider: Roth Capital Partners, Inc.
Analyst: BALDRY R